Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report)’s stock price crossed below its two hundred day moving average during trading on Friday. The stock has a two hundred day moving average of $5.02 and traded as low as $4.91. Ono Pharmaceutical shares last traded at $4.94, with a volume of 39,150 shares traded.
Ono Pharmaceutical Trading Down 3.3%
The business has a fifty day moving average price of $5.02 and a 200 day moving average price of $5.02.
About Ono Pharmaceutical
Ono Pharmaceutical Co, Ltd. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and commercialization of prescription medicines. The company focuses on areas including oncology, immunology, neurology and other serious diseases, with an emphasis on discovering therapies that address unmet medical needs.
Ono is best known for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb. Opdivo is used in multiple cancer indications, depending on regulatory approval in individual markets.
Featured Stories
- Five stocks we like better than Ono Pharmaceutical
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Receive News & Ratings for Ono Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ono Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.
